Evidence map›Paper›PMID 27057170›Full record

ArticleStem cells international2016

Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability.

Pietro Randelli, Alessandra Menon, Vincenza Ragone, Pasquale Creo, Sonia Bergante, Filippo Randelli, Laura De Girolamo, Umberto Alfieri Montrasio, Giuseppe Banfi, Paolo Cabitza and 2 more

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Stem cells international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03922490 phase4terminatednot on this mapstarted 2019, after this paper: background citation

Adipose Derived Stromal Cell Transplantation as an Adjunct to Arthroscopy in Treatment of Effusion Synovitis of the Early Degenerative Knee

TypeinterventionalSponsorHospital for Special Surgery, New YorkRan2019 to 2020Enrolled2ConditionsKnee OsteoarthritisArmsLipogems Device PLUS debridement, Debridement only
NCT04136743 phase2unknown statusnot on this mapstarted 2019, after this paper: background citation

Ultrasound-Guided Treatments for Chronic Shoulder Pain in Wheelchair Users With Spinal Cord Injury: A Randomized Controlled Trial

TypeinterventionalSponsorKessler FoundationRan2019 to 2024Enrolled24ConditionsSpinal Cord Injuries, Tendinopathy, Rotator Cuff Tears, Shoulder PainArmsLipogems, Dexamethasone
NCT06960343 recruitingnot on this mapstarted 2025, after this paper: background citation

Long Term Clinical Outcome After Arthroscopic Rotator Cuff Repair Augmentation With Autologous Microfragmented Lipoaspirate Tissue: a Prospective Randomized Controlled Trialin Question Won by Our Research Group.

TypeobservationalSponsorUniversity of MilanRan2025 to 2026Enrolled52ConditionsArthroscopic Rotator Cuff Repair, Augmentation, Microfragmented Adipose TissueArmsmagnetic resonance imaging (MRI), VAS, SST, ASES, CMS scores, and strength measurements in external rotation and abduction
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Pietro RandelliIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy; Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Alessandra MenonIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Vincenza RagoneIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Pasquale CreoIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Sonia BerganteIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Filippo RandelliIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Laura De GirolamoIRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy.
Umberto Alfieri MontrasioIRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy.
Giuseppe BanfiIRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy; Università Vita-Salute San Raffaele, 20132 Milan, Italy.
Paolo CabitzaIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Guido TettamantiIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.
Luigi AnastasiaIRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy; Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
IRCCS Policlinico San Donato · ITIstituto Ortopedico Galeazzi · ITUniversity of Milan · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing the success rate of rotator cuff healing remains tremendous challenge. Among many approaches, the possibility of activating resident stem cells in situ, without the need to isolate them from biopsies, could represent valuable therapeutic strategy. Along this line, it has been recently demonstrated that lipoaspirate product, Lipogems, contains and produces growth-factors that may activate resident stem cells. In this study, human tendon stem cells (hTSCs) from the rotator cuff were cocultured in a transwell system with the Lipogems lipoaspirate product and compared to control untreated cells in terms of cell proliferation, morphology, stem cell marker and VEGF expression, and differentiation and migration capabilities. Results showed that the Lipogems product significantly increases the proliferation rate of hTSCs without altering their stemness and differentiation capability. Moreover, treated cells increase the expression of VEGF, which is crucial for the neovascularization of the tissue during the healing process. Overall, this study supports that directly activating hTSCs with the Lipogems lipoaspirate could represent a new practical therapeutic approach. In fact, obtaining a lipoaspirate is easier, safer, and more cost-effective than harvesting cells from tendon or bone marrow biopsies, expanding them in GMP facility and then reinjecting them in the patient.

Identifiers

PMID27057170
PMCPMC4736573
OpenAlexW2222216545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.